QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cruz-Monserrate, Z. Articles by Hamel, E. Search for Related Content PubMed PubMed Citation Articles by Cruz-Monserrate, Z. Articles by Hamel, E.

Diazonamide A and a Synthetic Structural Analog: Disruptive Effects on Mitosis and Cellular Microtubules and Analysis of Their Interactions with Tubulin

Screening Technologies Branch (Z.C.-M., R.B., E.H.) and Natural Products Branch (D.J.N.), Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, National Institutes of Health, Frederick, Maryland; Center for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography (H.C.V., W.F.) and Department of Medicine and the Cancer Center (S.B.H., G.L.), University of California at San Diego, La Jolla, California; and Department of Chemistry and Biochemistry and Cancer Research Institute, Arizona State University, Tempe, Arizona (J.T.M., M.D.W., G.R.P.)

The marine ascidian Diazona angulata was the source organism for the complex cytotoxic peptide diazonamide A. The molecular structure of this peptide was recently revised after synthesis of a biologically active analog of diazonamide A in which a single nitrogen atom was replaced by an oxygen atom. Diazonamide A causes cells to arrest in mitosis, and, after exposure to the drug, treated cells lose both interphase and spindle microtubules. Both diazonamide A and the oxygen analog are potent inhibitors of microtubule assembly, equivalent in activity to dolastatin 10 and therefore far more potent than dolastatin 15. This inhibition of microtubule assembly is accompanied by potent inhibition of tubulin-dependent GTP hydrolysis, also comparable with the effects observed with dolastatin 10. However, the remaining biochemical properties of diazonamide A and its analog differ markedly from those of dolastatin 10 and closely resemble the properties of dolastatin 15. Neither diazonamide A nor the analog inhibited the binding of [³H]vinblastine, [³H]dolastatin 10, or [8-¹⁴C]GTP to tubulin. Nor were they able to stabilize the colchicine binding activity of tubulin. These observations indicate either that diazonamide A and the analog have a unique binding site on tubulin differing from the vinca alkaloid and dolastatin 10 binding sites, or that diazonamide A and the analog bind weakly to unpolymerized tubulin but strongly to microtubule ends. If the latter is correct, diazonamide A and its oxygen analog should have uniquely potent inhibitory effects on the dynamic properties of microtubules.

Received November 4, 2002; accepted February 24, 2003.

Address correspondence to: Dr. E. Hamel, Building 469, Room 104, National Cancer Institute at Frederick, Frederick, MD 21702. E-mail: hamele{at}mail.nih.gov

This article has been cited by other articles:

				G. Wang, L. Shang, A. W. G. Burgett, P. G. Harran, and X. Wang Diazonamide toxins reveal an unexpected function for ornithine {delta}-amino transferase in mitotic cell division PNAS, February 13, 2007; 104(7): 2068 - 2073. [Abstract] [Full Text] [PDF]

				N. S. Williams, A. W. G. Burgett, A. S. Atkins, X. Wang, P. G. Harran, and S. L. McKnight Therapeutic anticancer efficacy of a synthetic diazonamide analog in the absence of overt toxicity PNAS, February 13, 2007; 104(7): 2074 - 2079. [Abstract] [Full Text] [PDF]